The Deal - Dealmaking Insights & Analysis

Restructuring

Binaca, VO5 Shampoo Maker Pursues Sale in Chapter 11

By David Elman

Published: December 18th, 2019

The private equity-backed maker of personal care products such as Zest soap and Binaca breath spray will continue to explore a sale under bankruptcy protection.

M&A

IFF Backs Into DuPont Nutrition & Science

By Paul Whitfield

Published: December 17th, 2019

The reverse takeover values the DuPont unit at $26.2 billion.

M&A

WPX Energy Picks Up Longtime Target Felix

By Tom Terrarosa

Published: December 17th, 2019

The oil producer will pay $2.5 billion for the EnCap Investments portfolio company.

M&A

Post-Merger T-Mobile Won’t Be Maverick: States’ Expert

By Chris Nolter

Published: December 12th, 2019

An expert witness for the group of states suing to block T-Mobile's purchase of Sprint testified that the post-merger company would likely lose its zeal for aggressive price competition.

Private Equity

Middle-Market Digest: How Olympus Sourced Heniff and More

By Steve Gelsi

Published: December 12th, 2019

A compilation of middle market and growth equity deals under $500 million between Nov. 22 and Dec. 5.

Private Equity

Family Offices and PE: Can’t We All Get Along

Published: December 11th, 2019

M&A

Merck Expands Oncology Pipeline With ArQule

Published: December 9th, 2019

The biopharmaceutical giant is paying a 107% premium for the target, which focuses on therapies for treating cancer and rare diseases.

M&A

Drinks With The Deal: Chris Varelas

By David Marcus

Published: December 6th, 2019

The former Citi tech investment banker and author of 'How Money Became Dangerous' talks with The Deal’s David Marcus about working at Disneyland in the 1980s, being a tech banker after the dot-com crash and investing in influencers.

Activism

Inside Hudson Executive’s USA Tech Battle

By Ronald Orol